Does Dr. RAKHI AMMAR have financial conflicts of interest?

Dr. RAKHI AMMAR (MD) has received a total of $7,450 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $7,450 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAKHI AMMAR?

According to CMS Open Payments data, Dr. RAKHI AMMAR received funding from GLAUKOS CORPORATION ($2,415), ALCON VISION ($1,978), and REGENERON PHARMACEUTICALS ($1,393).

Does Dr. RAKHI AMMAR receive research grants or speaking fees?

Dr. RAKHI AMMAR has received $7,450 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAKHI AMMAR

MDReal-Time Hydrated

Specialty: Ophthalmology, Cornea and External Diseases Specialist

Practice Location: LA JOLLA, CA 92037

NPI Number: 1285138503

LIFETIME INDUSTRY VALUE

$7,450

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AMMAR is a verified Ophthalmology, Cornea and External Diseases Specialist practitioner based in LA JOLLA, CA.

Between 2021 and 2024, Dr. AMMAR had an overall industry promotional and research financial footprint of $7,450 as recorded in the federal CMS Open Payments database.

$7,450 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AMMAR's primary funding source is GLAUKOS CORPORATION, which accounts for $2,415 (representing 32.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAUKOS CORPORATION

Rank 1

$2,415

32.4%

ALCON VISION

Rank 2

$1,978

26.6%

REGENERON PHARMACEUTICALS

Rank 3

$1,393

18.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.